| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Changes in Prostate-specific Antigen Screening after the 2018 United States Preventive Services Task Force Recommendations and Through the COVID-19 Pandemic
|
Qian, Zhiyu
|
|
|
7 |
1 |
p. 151-154
|
artikel
|
| 2 |
Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review
|
Crupi, Emanuele
|
|
|
7 |
1 |
p. 44-52
|
artikel
|
| 3 |
Contents
|
|
|
|
7 |
1 |
p. iii-v
|
artikel
|
| 4 |
Defining the Role of Large Language Models in Urologic Care and Research
|
Gupta, Raghav
|
|
|
7 |
1 |
p. 1-13
|
artikel
|
| 5 |
Development of a Personalized Chat Model Based on the European Association of Urology Oncology Guidelines: Harnessing the Power of Generative Artificial Intelligence in Clinical Practice
|
Khene, Zine-Eddine
|
|
|
7 |
1 |
p. 160-162
|
artikel
|
| 6 |
Does Research from Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer Treatment Translate into Access to Treatments for Patients in the “Real World”? A Systematic Review
|
Dodkins, Joanna
|
|
|
7 |
1 |
p. 14-24
|
artikel
|
| 7 |
Downstaging and Survival Associated with Neoadjuvant Immunotherapy Before Radical Cystectomy for Muscle-invasive Bladder Cancer
|
Grassauer, Jacob
|
|
|
7 |
1 |
p. 139-146
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
7 |
1 |
p. i-ii
|
artikel
|
| 9 |
Efficacy and Effectiveness: Bridging the Gap Between Clinical Trials and Real-world Practice
|
Nguyen, David-Dan
|
|
|
7 |
1 |
p. 25-26
|
artikel
|
| 10 |
First-in-human Evaluation of a Prostate-specific Membrane Antigen–targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy
|
Nguyen, Hao G.
|
|
|
7 |
1 |
p. 63-72
|
artikel
|
| 11 |
Large Language Models in Uro-oncology
|
Ferber, Dyke
|
|
|
7 |
1 |
p. 157-159
|
artikel
|
| 12 |
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524—A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation
|
Dahl, Douglas M.
|
|
|
7 |
1 |
p. 83-90
|
artikel
|
| 13 |
Peritoneal Flap for Lymphocele Prophylaxis Following Robotic-assisted Radical Prostatectomy with Lymph Node Dissection: The Randomised Controlled Phase 3 PELYCAN Trial
|
Neuberger, Manuel
|
|
|
7 |
1 |
p. 53-62
|
artikel
|
| 14 |
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy
|
Wu, Zhenjie
|
|
|
7 |
1 |
p. 112-121
|
artikel
|
| 15 |
Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes
|
Eckstein, Markus
|
|
|
7 |
1 |
p. 128-138
|
artikel
|
| 16 |
Prospective Validation Study of a Novel Integrated Pathway Based on Clinical Features, Magnetic Resonance Imaging Biomarkers, and MicroRNAs for Early Detection of Prostate Cancer
|
Pecoraro, Martina
|
|
|
7 |
1 |
p. 73-82
|
artikel
|
| 17 |
Randomized Controlled Feasibility Trial of Robot-assisted Versus Conventional Open Partial Nephrectomy: The ROBOCOP II Study
|
Kowalewski, Karl-Friedrich
|
|
|
7 |
1 |
p. 91-97
|
artikel
|
| 18 |
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
|
Santoni, Matteo
|
|
|
7 |
1 |
p. 102-111
|
artikel
|
| 19 |
Re: Bradley McGregor, Daniel M. Geynisman, Mauricio Burotto, et al. A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma. Eur Urol Oncol. 2023;6:339–348
|
Chadha, Juskaran
|
|
|
7 |
1 |
p. 172
|
artikel
|
| 20 |
Re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol 2023;41:2428–35
|
Falagario, Ugo Giovanni
|
|
|
7 |
1 |
p. 167-168
|
artikel
|
| 21 |
Re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging After Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629–634
|
Abreu-Gomez, Jorge
|
|
|
7 |
1 |
p. 169-170
|
artikel
|
| 22 |
Re: Freddie C. Hamdy, Jennie L. Donovan, J. Athene Lane, et al. Fifteen-year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547–58
|
Campodonico, Fabio
|
|
|
7 |
1 |
p. 171
|
artikel
|
| 23 |
Reply to Ugo Giovanni Falagario, Alberto Martini, Francesco Pellegrino, et al.’s Letter to the Editor re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol 2023;41:2428–35
|
Tilki, Derya
|
|
|
7 |
1 |
p. 166
|
artikel
|
| 24 |
Reply to Wen-Wei Sung’s Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023;6:531–534
|
Tan, Wei Shen
|
|
|
7 |
1 |
p. 164-165
|
artikel
|
| 25 |
Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS)
|
Heidenreich, Axel
|
|
|
7 |
1 |
p. 122-127
|
artikel
|
| 26 |
Re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023;6:531–534
|
Sung, Wen-Wei
|
|
|
7 |
1 |
p. 163
|
artikel
|
| 27 |
Robotic Versus Open Partial Nephrectomy: From the “Shadows” of Randomized Controlled Trials to the “Reality” of Value-based Care for Patients with Localized Renal Masses
|
Campi, Riccardo
|
|
|
7 |
1 |
p. 98-101
|
artikel
|
| 28 |
Stereotactic Magnetic Resonance–guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental Cohort
|
Yim, Kendrick
|
|
|
7 |
1 |
p. 147-150
|
artikel
|
| 29 |
The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature
|
Sood, Akshay
|
|
|
7 |
1 |
p. 27-43
|
artikel
|
| 30 |
Would Uro_Chat, a Newly Developed Generative Artificial Intelligence Large Language Model, Have Successfully Passed the In-Service Assessment Questions of the European Board of Urology in 2022?
|
May, Matthias
|
|
|
7 |
1 |
p. 155-156
|
artikel
|
Tijdschrift beschrijving